Stickelmeyer M - Search Results

1

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.

McDonnell DP, Detke HC, Bergstrom RF, Kothare P, Johnson J, Stickelmeyer M, Sanchez-Felix MV, Sorsaburu S, Mitchell MI. McDonnell DP, et al. Among authors: stickelmeyer m. BMC Psychiatry. 2010 Jun 10;10:45. doi: 10.1186/1471-244X-10-45. BMC Psychiatry. 2010. PMID: 20537130 Free PMC article.

2

FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.

Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, Kraemer J, Morris JM, Reppas C, Stickelmeyer MP, Yomota C, Shah VP. Brown CK, et al. Among authors: stickelmeyer mp. AAPS PharmSciTech. 2011 Jun;12(2):782-94. doi: 10.1208/s12249-011-9634-x. Epub 2011 Jun 18. AAPS PharmSciTech. 2011. PMID: 21688063 Free PMC article.

3

FIP Guidelines for Dissolution Testing of Solid Oral Products.

Friedel HD, Brown CK, Barker AR, Buhse LF, Keitel S, Kraemer J, Morris JM, Reppas C, Sperry DC, Sakai-Kato K, Stickelmeyer MP, Shah VP. Friedel HD, et al. Among authors: stickelmeyer mp. J Pharm Sci. 2018 Dec;107(12):2995-3002. doi: 10.1016/j.xphs.2018.08.007. Epub 2018 Aug 25. J Pharm Sci. 2018. PMID: 30148985

4

FIP position paper on qualification of paddle and basket dissolution apparatus.

Brown CK, Buhse L, Friedel HD, Keitel S, Kraemer J, Morris JM, Stickelmeyer M, Yomota C, Shah VP; International Pharmaceutical Federation. Brown CK, et al. Among authors: stickelmeyer m. AAPS PharmSciTech. 2009;10(3):924-7. doi: 10.1208/s12249-009-9291-5. Epub 2009 Jul 16. AAPS PharmSciTech. 2009. PMID: 19609681 Free PMC article.

5

Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties.

Richards JP, Stickelmeyer MP, Frank BH, Pye S, Barbeau M, Radziuk J, Smith GD, DeFelippis MR. Richards JP, et al. Among authors: stickelmeyer mp. J Pharm Sci. 1999 Sep;88(9):861-7. doi: 10.1021/js990107o. J Pharm Sci. 1999. PMID: 10479347

6

Biorelevant in vitro performance testing of orally administered dosage forms-workshop report.

Reppas C, Friedel HD, Barker AR, Buhse LF, Cecil TL, Keitel S, Kraemer J, Morris JM, Shah VP, Stickelmeyer MP, Yomota C, Brown CK. Reppas C, et al. Among authors: stickelmeyer mp. Pharm Res. 2014 Jul;31(7):1867-76. doi: 10.1007/s11095-014-1348-9. Epub 2014 Mar 19. Pharm Res. 2014. PMID: 24643933

7

Formulation development of protein dosage forms.

Akers MJ, Vasudevan V, Stickelmeyer M. Akers MJ, et al. Among authors: stickelmeyer m. Pharm Biotechnol. 2002;14:47-127. doi: 10.1007/978-1-4615-0549-5_2. Pharm Biotechnol. 2002. PMID: 12189730 Review. No abstract available.

8

Self-association properties of monomeric insulin analogs under formulation conditions.

Richards JP, Stickelmeyer MP, Flora DB, Chance RE, Frank BH, DeFelippis MR. Richards JP, et al. Among authors: stickelmeyer mp. Pharm Res. 1998 Sep;15(9):1434-41. doi: 10.1023/a:1011961923870. Pharm Res. 1998. PMID: 9755897

9

Stability of U-10 and U-50 dilutions of insulin lispro.

Stickelmeyer MP, Graf CJ, Frank BH, Ballard RL, Storms SM. Stickelmeyer MP, et al. Diabetes Technol Ther. 2000 Spring;2(1):61-6. doi: 10.1089/152091599316757. Diabetes Technol Ther. 2000. PMID: 11467323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters